Westlake Chemical Partners LP— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$323M
↑+11.4% +$33Mvs FY2024 (Q4)
Gross Profit
$97M
↓-1.8% -$2Mvs FY2024 (Q4)
Operating Income
$90M
↓-2.5% -$2Mvs FY2024 (Q4)
Net Income
$15M
↓-3.0% -$457Kvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $323M | $290M |
| COGS | $226M | $191M |
| Gross Profit | $97M | $99M |
| R&D | $0 | $0 |
| SG&A | $7M | $7M |
| D&A | $0 | $0 |
| Other OpEx | $0 | $0 |
| Operating Income | $90M | $92M |
| Interest Exp. | $5M | $4M |
| Other Non-Op | $0 | $0 |
| Pretax Income | $84M | $88M |
| Tax | $70M | $73M |
| Net Income | $15M | $15M |
QuarterCharts · SEC EDGAR data · WLKP · Comparing FY2025 (Q4) vs FY2024 (Q4)